The resulting diagnostic cutoffs not only helped to exclude the diagnosis of AIS in many cases but also lead to the identification of an androgen-resistant but AR-CDS-negative new class of AIS, which we suggest to call AIS type II. This evidence concerns the gene AR and androgen insensitivity syndrome.